Abstract
Population-based studies indicate that chemoradiation has become the most popular treatment for advanced laryngeal cancers; however, by extrapolating trial results to the general population, several issues have emerged, such as reduced overall survival, non-functional laryngeal preservation, and poor response to treatment. Although included in these trials, T4 laryngeal and hypopharyngeal cancers with cartilage invasion formed a small percentage of these patients and questions over whether they were appropriately staged remain unanswered. Literature on the use of chemoradiation in this set of patients, including the challenges, treatment considerations, and factors predicting response to treatment and outcomes, was reviewed. Current evidence indicates that all patients of T4 laryngeal and hypopharyngeal cancer are not suitable candidates for organ preservation; this modality should be offered only to select patients with good performance status and access to rehabilitative care and regular follow-up in order to achieve good results.
Similar content being viewed by others
References
The Department of Veteran Affairs Laryngeal Cancer Study Group (1991) Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med 324(24):1685–1690
Richard JM, Sancho-Garnier H, Pessey JJ, Luboinski B, Lefebvre JL, Dehesdin D, Stromboni-Luboinski M, Hill C (1998) Randomized trial of induction chemotherapy in larynx carcinoma. Oral Oncol 34(3):224–228
Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Glisson B, Trotti A, Ridge JA, Chao C, Peters G, Lee DJ, Leaf A, Ensley J, Cooper J (2003) Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 349(22):2091–2098
Pfister DG, Laurie SA, Weinstein GS, Mendenhall WM, Adelstein DJ, Ang KK et al (2006) American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol Off J Am Soc Clin Oncol 24(22):3693–3704
Carvalho AL, Nishimoto IN, Califano JA, Kowalski LP (2005) Trends in incidence and prognosis for head and neck cancer in the United States: a site- specific analysis of the SEER database. Int J Cancer 114(5):806–816
Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA (2006) Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 116(9 Pt 2 Suppl 111):1–13
Megwalu UC, Sikora AG (2014) Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg 140(9):855–860
Chen AY, Fedewa S, Zhu J (2011) Temporal trends in the treatment of early- and advanced-stage laryngeal cancer in the United States,1985-2007. Arch Otolaryngol Head Neck Surg 137(10):1017–1024
O’Neill CB, O’Neill JP, Atoria CL, Baxi SS, Henman MC, Ganly I, Elkin EB (2014) Treatment complications and survival in advanced laryngeal cancer: a population-based analysis. Laryngoscope 124(12):2707–2713
Timmermans AJ, van Dijk BA, Overbeek LI, van Velthuysen ML, van Tinteren H, Hilgers FJ et al (2016) Trends in treatment and survival for advanced laryngeal cancer: a 20-year population-based study in The Netherlands. Head Neck 38(Suppl 1):E1247–E1255
Sanabria A, Chaves AL, Kowalski LP, Wolf GT, Saba NF, Forastiere AA et al (2017) Organ preservation with chemoradiation in advanced laryngeal cancer: the problem of generalizing results from randomized controlled trials. Auris Nasus Larynx 44(1):18–25
Isseroff TF, Parasher AK, Richards A, Sivak M, Woo P (2016) Interrater reliability in analysis of laryngoscopic features for unilateral vocal fold paresis. J Voice 30(6):736–740
Beitler JJ, Muller S, Grist WJ, Corey A, Klein AM, Johns MM, Perkins CL, Davis LW, Udayasanker U, Landry JC, Shin DM, Hudgins PA (2010) Prognostic accuracy of computed tomography findings for patients with laryngeal cancer undergoing laryngectomy. J Clin Oncol 28(14):2318–2322
Agada FO, Nix PA, Salvage D, Stafford ND (2004) Computerised tomography vs. pathological staging of laryngeal cancer: a 6-year completed audit cycle. Int J Clin Pract 58(7):714–716
Nakayama M, Okamoto M, Hayakawa K, Miyamoto S, Ishiyama H, Komori S, Okamoto T, Seino Y, Kano K, Soda I, Sekiguchi A, Kawakami S (2014) Clinical outcomes of 849 laryngeal cancers treated in the past 40 years: are we succeeding? Jpn J Clin Oncol 44(1):57–64
Nordsmark M, Bentzen SM, Rudat V, Brizel D, Lartigau E, Stadler P, Becker A, Adam M, Molls M, Dunst J, Terris DJ, Overgaard J (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multicenter study. Radiother Oncol 77(1):18–24
Pfister DG, Ang KK, Brizel DM, Burtness BA, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Kies MS, Lydiatt WM, Maghami E, Martins R, McCaffrey T, Mittal BB, Pinto HA, Ridge JA, Samant S, Schuller DE, Shah JP, Spencer S, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M, National Comprehensive Cancer Network (2013) Head and neck cancers, version 2.2013. Featured updates to the NCCN guidelines. Journal of the National Comprehensive Cancer Network. JNCCN 11(8):917–923
Dziegielewski PT, O’Connell DA, Klein M, Fung C, Singh P, Alex Mlynarek M et al (2012) Primary total laryngectomy versus organ preservation for T3/T4a laryngeal cancer: a population-based analysis of survival. J Otolaryngol Head Neck Surg 41(Suppl 1):S56–S64
Gourin CG, Conger BT, Sheils WC, Bilodeau PA, Coleman TA, Porubsky ES (2009) The effect of treatment on survival in patients with advanced laryngeal carcinoma. Laryngoscope 119(7):1312–1317
Rosenthal DI, Mohamed AS, Weber RS, Garden AS, Sevak PR, Kies MS et al (2015) Long-term outcomes after surgical or nonsurgical initial therapy for patients with T4 squamous cell carcinoma of the larynx: a 3-decade survey. Cancer 121(10):1608–1619
Vengalil S, Giuliani ME, Huang SH, McNiven A, Song Y, Xu W, Chan B, Hope A, Cho J, Bayley A, Ringash J, Goldstein D, Razak A, Irish J, Gilbert R, Gullane P, Waldron J, Kim J, O’Sullivan B (2016) Clinical outcomes in patients with T4 laryngeal cancer treated with primary radiotherapy versus primary laryngectomy. Head Neck 38(Suppl 1):E2035–E2040
Hanna E, Sherman A, Cash D, Adams D, Vural E, Fan CY, Suen JY (2004) Quality of life for patients following total laryngectomy vs chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 130(7):875–879
Terrell JE, Fisher SG, Wolf GT (1998) Long-term quality of life after treatment of laryngeal cancer. The Veterans Affairs Laryngeal Cancer Study Group. Arch Otolaryngol Head Neck Surg 124(9):964–971
Trivedi NP, Swaminathan DK, Thankappan K, Chatni S, Kuriakose MA, Iyer S (2008) Comparison of quality of life in advanced laryngeal cancer patients after concurrent chemoradiotherapy vs total laryngectomy. Otolaryngol Head Neck Surg 139(5):702–707
Dyckhoff G, Plinkert PK, Ramroth H (2017) A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients. BMC Cancer 17(1):609
Stokes WA, Jones BL, Bhatia S, Oweida AJ, Bowles DW, Raben D, Goddard JA, McDermott JD, Karam SD (2017) A comparison of overall survival for patients with T4 larynx cancer treated with surgical versus organ-preservation approaches: a National Cancer Data Base analysis. Cancer 123(4):600–608
Choi YS, Park SG, Song EK, Cho SH, Park MR, Park KU, Lee KH, Song IC, Lee HJ, Jo DY, Kim S (2016) Comparison of the therapeutic effects of total laryngectomy and a larynx-preservation approach in patients with T4a laryngeal cancer and thyroid cartilageinvasion: a multicenter retrospective review. Head Neck 38(8):1271–1277
Patel UA, Howell LK (2011) Local response to chemoradiation in T4 larynx cancer with cartilage invasion. Laryngoscope 121(1):106–110
Urba S, Wolf G, Eisbruch A, Worden F, Lee J, Bradford C, Teknos T, Chepeha D, Prince M, Hogikyan N, Taylor J (2006) Single-cycle induction chemotherapy selects patients with advanced laryngeal cancer for combined chemoradiation: a new treatment paradigm. J Clin Oncol 24(4):593–598
Knab BR, Salama JK, Stenson KM, Cohen EE, List MA, Witt ME et al (2006) 24. Definitive Chemoradiotherapy for T4 laryngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 66(3, Supplement):S14
Worden FP, Moyer J, Lee JS, Taylor JMG, Urba SG, Eisbruch A, Teknos TN, Chepeha DB, Prince ME, Hogikyan N, Lassig AAD, Emerick K, Mukherji S, Hadjiski L, Tsien CI, Miller TH, Wallace NE, Mason HL, Bradford CR, Wolf GT (2009) Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope 119(8):1510–1517
Popovtzer A, Burnstein H, Stemmer S, Limon D, Hili O, Bachar G, Sopov V, Feinmesser R, Groshar D, Shvero J (2017) Phase II organpreservation trial: concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil–based induction chemotherapy. Head Neck 39(2):227–233
Chung MK, Jeong H-S, Park SG, Jang JY, Son Y-I, Choi JY, Hyun SH, Park K, Ahn MJ, Ahn YC, Kim HJ, Ko YH, Baek CH (2009) Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal Cancer. Clin Cancer Res 15:5861–5868
La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K et al (2009) Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. Int J Radiat Oncol Biol Phys 74(5):1335–1341
Murphy JD, La TH, Chu K, Quon A, Fischbein NJ, Maxim PG et al (2011) Post-radiation metabolic tumor volume predicts outcome in head-and- neck cancer. Int J Radiat Oncol Biol Phys 80(2):514–521
Park GC, Kim JS, Roh JL, Choi SH, Nam SY, Kim SY (2013) Prognostic value of metabolic tumor volume measured by 18FFDG PET/CT in advanced- stage squamous cell carcinoma of the larynx and hypopharynx. Ann Oncol 24(1):208–214
Tang C, Murphy JD, Khong B, La TH, Kong C, Fischbein NJ et al (2012) Validation that metabolic tumor volume predicts outcome in head-and-neck cancer. Int J Radiat Oncol Biol Phys 83(5):1514–1520
Choi K-H, Yoo IR, Han EJ, Kim YS, KimGW NSJ, Sun DI, Jung SL, Jung CK, Kim MS, Lee SY, Kim SH (2011) Prognostic value of metabolic tumor volume measured by (18)F-FDG PET/CT in locally advanced head and neck squamous cell carcinomas treated by surgery. Nucl Med Mol Imaging 45(1):43–51
Sanabria A, Domenge C, D’Cruz A, Kowalski LP (2010) Organ preservation protocols in developing countries. Curr Opin Otolaryngol Head Neck Surg 18(2):83–88
Strojan P, Haigentz M Jr, Bradford CR, Wolf GT, Hartl DM, Langendijk JA, Rinaldo A, Eisbruch A, Mendenhall WM, Forastiere AA, Takes RP, Ferlito A (2013) Chemoradiotherapy vs. total laryngectomy for primary treatment of advanced laryngeal squamous cell carcinoma. Oral Oncol 49(4):283–286
Minn H, Lapela M, Klemi PJ, Grénman R, Leskinen S, Lindholm P et al (1997) Prediction of survival with fluorine-18-fluorodeoxyglucose and PET in head and neck cancer. J Nucl Med 38:1907–1911
Hanamoto A, Tatsumi M, Takenaka Y, Hamasaki T, Yasui T, Nakahara S, Yamamoto Y, Seo Y, Isohashi F, Ogawa K, Hatazawa J, Inohara H (2014) Volumetric PET/CT parameters predict local response of head and neck squamous cell carcinoma to chemoradiotherapy. Cancer Med 3(5):1368–1376
Pak K, Cheon GJ, Nam HY, Kim SJ, Kang KW, Chung JK, Kim EE, Lee DS (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis in head and neck cancer: a systematic review and meta-analysis. J Nucl Med 55(6):884–890
McNeil BJ, Weichselbaum R, Pauker SG (1981) Speech and survival: tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 305(17):982–987
Laccourreye O, Malinvaud D, Holsinger FC, Consoli S, Menard M, Bonfils P (2012) Trade-off between survival and laryngeal preservation in advanced laryngeal cancer: the otorhinolaryngology patient’s perspective. Ann Otol Rhinol Laryngol 121(9):570–575
Forastiere AA, Zhang Q, Weber RS, Maor MH, Goepfert H, Pajak TF, Morrison W, Glisson B, Trotti A, Ridge JA, Thorstad W (2012) Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol 31(7):845–852
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Subramaniam, N., Balasubramanian, D., Reddy, R. et al. Organ Preservation Protocols in T4 Laryngeal Cancer: a Review of the Literature. Indian J Surg Oncol 10, 149–155 (2019). https://doi.org/10.1007/s13193-018-0840-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-018-0840-9